[Complications of medical therapy for epilepsy in children and adolescents].
D000927:Anticonvulsants / Q000009:adverse effects*; D002648:Child; D004172:Diplopia / Q000139:chemically induced; D004342:Drug Hypersensitivity; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000188:drug therapy*; D006261:Headache / Q000139:chemically induced; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced*; D009069:Movement Disorders / Q000139:chemically induced*; D009759:Nystagmus, Pathologic / Q000139:chemically induced; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011324:Primidone / Q000009:adverse effects; D013064:Speech Disorders / Q000139:chemically induced; D014717:Vertigo / Q000139:chemically induced
D000927:Anticonvulsants; D011324:Primidone; D010672:Phenytoin; D010634:Phenobarbital
Oslozhneniia medikamentoznoĭ terapii épilepsii u deteĭ i podrostkov.